Compounds
TB Alliance is searching for new, faster-acting, and affordable treatments. The following list details compounds, approved TB drugs, and discovery projects that exist within one or more of TB Alliance’s research programs.
- Evotec
- University of Illinois at Chicago, Harvard University
- University of Illinois at Chicago, Harvard University, Global Health Drug Discovery Institute
- University of Auckland, University of Illinois at Chicago
- GlaxoSmithKline, Evotec
- ERA4TB, Qurient Therapeutics
- Texas A&M University
- Texas A&M University, Weill Cornel Medical
- AbbVie, ERA4TB
- Evotec
- Bill & Melinda Gates Foundation
- Schrodinger, University of Auckland
- Evotec, Texas A&M University, Weill Cornel Medical, University of North Carolina
- Johns Hopkins University, TB Drug Accelerator Program, ERA4TB
- Qurient Therapeutics
- University of Auckland, Lgenia
- Bill & Melinda Gates Medical Research Institute
- Foundation for Neglected Disease Research, Bill & Melinda Gates Medical Research Institute
- ERA4TB
- Institute of Materia Medica
- GlaxoSmithKline